Surrozen, Inc. Common

SRZN XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

270M

Short interest (May 15)

4.7%

Net Short (Jun 03 ): 0.0%

Borrow Fee

3.50%

↓ 16.9%

Available Shares

300K

↓ 9.7%

Price Chart

Company Overview

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001824893

Asset Type: CS

Market Data

Market Cap: $268,722,036

Employees: 44

Status: Active

Short Interest

Current Borrow Fee 3.50%

Range: 3.50% - 3.80%

Available Shares 300K

Range: 150K - 250K

Recent Changes

Fee Change: ↑ 0.9%

Available Change: ↑ 25.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime